Literature DB >> 18319255

Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.

Yu Wang1, Alvin T C Lee, Joel Z I Ma, Jingbo Wang, Jianwei Ren, Yuchen Yang, Erwin Tantoso, Kuo-Bin Li, London L P J Ooi, Patrick Tan, Caroline G L Lee.   

Abstract

Like other cancers, aberrant gene regulation features significantly in hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) were recently found to regulate gene expression at the post-transcriptional/translational levels. The expression profiles of 157 miRNAs were examined in 19 HCC patients, and 19 up-regulated and 3 down-regulated miRNAs were found to be associated with HCC. Putative gene targets of these 22 miRNAs were predicted in silico and were significantly enriched in 34 biological pathways, most of which are frequently dysregulated during carcinogenesis. Further characterization of microRNA-224 (miR-224), the most significantly up-regulated miRNA in HCC patients, revealed that miR-224 increases apoptotic cell death as well as proliferation and targets apoptosis inhibitor-5 (API-5) to inhibit API-5 transcript expression. Significantly, miR-224 expression was found to be inversely correlated with API-5 expression in HCC patients (p < 0.05). Hence, our findings define a true in vivo target of miR-224 and reaffirm the important role of miRNAs in the dysregulation of cellular processes that may ultimately lead to tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18319255     DOI: 10.1074/jbc.M707629200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  156 in total

1.  Negative feedback of miR-29 family TET1 involves in hepatocellular cancer.

Authors:  Li Li Lin; Wei Wang; ZhaoYang Hu; Li Wen Wang; Jing Chang; HanGuang Qian
Journal:  Med Oncol       Date:  2014-11-04       Impact factor: 3.064

2.  WDR36 and P53 gene variants and susceptibility to primary open-angle glaucoma: analysis of gene-gene interactions.

Authors:  Cristina Blanco-Marchite; Francisco Sánchez-Sánchez; María-Pilar López-Garrido; Mercedes Iñigez-de-Onzoño; Francisco López-Martínez; Enrique López-Sánchez; Lydia Alvarez; Pedro-Pablo Rodríguez-Calvo; Carmen Méndez-Hernández; Luis Fernández-Vega; Julián García-Sánchez; Miguel Coca-Prados; Julián García-Feijoo; Julio Escribano
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

3.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

4.  Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma.

Authors:  Lu Jiang; Yang Dai; Xiqiang Liu; Cheng Wang; Anxun Wang; Zujian Chen; Caroline E Heidbreder; Antonia Kolokythas; Xiaofeng Zhou
Journal:  Hum Genet       Date:  2010-11-16       Impact factor: 4.132

5.  MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.

Authors:  Xin Li; Wenfeng Zhang; Liya Zhou; Donghui Yue; Xin Su
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

Review 7.  Epigenetics of hepatocellular carcinoma: role of microRNA.

Authors:  Sharad Khare; Qiong Zhang; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

8.  miR-221 silencing blocks hepatocellular carcinoma and promotes survival.

Authors:  Jong-Kook Park; Takayuki Kogure; Gerard J Nuovo; Jinmai Jiang; Lei He; Ji Hye Kim; Mitch A Phelps; Tracey L Papenfuss; Carlo M Croce; Tushar Patel; Thomas D Schmittgen
Journal:  Cancer Res       Date:  2011-10-18       Impact factor: 12.701

9.  Transcriptional regulation of co-expressed microRNA target genes.

Authors:  Ying Wang; Xiaoman Li; Haiyan Hu
Journal:  Genomics       Date:  2011-10-02       Impact factor: 5.736

10.  Upregulated microRNA-224 promotes ovarian cancer cell proliferation by targeting KLLN.

Authors:  Ke Hu; Meng Liang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-09-23       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.